ClinicalTrials.Veeva

Menu

Red Blood Cell Distributions (RDW, RDW-CW) and Lymphocyte Monocyte Ratios (LMR) for the Malignant Thyroid Nodules

K

Kahramanmaraş Sütçü İmam University (KSU)

Status

Completed

Conditions

Thyroid Diseases
Thyroid Nodule
Thyroid Cancer
Thyroid Neoplasms Benign

Treatments

Procedure: Thyroidectomy, Unilaterally Total
Procedure: Thyroidectomy, Complementary
Procedure: Thyroidectomy, Near Total
Procedure: Thyroidectomy, Bilaterally Total

Study type

Observational

Funder types

Other

Identifiers

NCT06283368
2021/11-06

Details and patient eligibility

About

Thyroid surgery is the most common type of surgery among endocrine surgeries. This surgery is performed for patients with suspected malignancy, patients diagnosed with malignancy, and toxic nodular goiter. In addition to vocal cord injury, which is the most important complication of thyroid surgery, hypocalcemia due to hypoparathyroidism and surgical wound complications (such as hematoma, and fistula) can also be observed, and malignancy surgery increases the risk of recurrent laryngeal nerve injury. Therefore, it is important to differentiate these groups using non-invasive methods before surgery.

Tumor-related inflammation is activated as a result of bone marrow and inflammation induced by malignancies. Insufficiently controlled or uncontrolled inflammatory activity may be responsible for malignant transformation. Lymphocyte monocyte ratio and red blood cell distribution are parameters (RDW, RDW-CW) previously studied in terms of cancers.

Our aim in this study is to reveal the RDW, RDW-CW, and LMR calculated from complete blood count parameters in the preoperative period, as an indicator of malignant inflammatory response, in a non-invasive and inexpensive way before surgery or biopsy is performed to distinguish nodular goiter and thyroid malignancy.

Full description

Thyroid surgery patients older than 18 who were operated on at the Department of General Surgery of Kahramanmaras Sutcu Imam University between January 2016 and January 2021 for nodular goiter and thyroid malignancy (surgical procedures include bilateral total thyroidectomy, unilateral total thyroidectomy, bilateral subtotal thyroidectomy, unilateral subtotal thyroidectomy, bilateral near total, completion thyroidectomy for recurrent cases). Patients will be evaluated as malignant patients and patients with benign goiter diseases according to the pathology results. Lymphocyte-monocyte ratios will be calculated manually by recording lymphocyte numbers, monocyte numbers, and red blood cell distribution volumes (RDW and RDW-CW) in the routine complete blood count values of the patients in the preoperative period. Patient data will be accessed from the preoperative laboratory and postoperative pathology results recorded in patient epicrisis forms and the computer system.

Enrollment

172 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Older than 18 age
  • Thyroidectomy cases

Exclusion criteria

  • Younger than 18 age
  • Patients with other system malignancies
  • Patients with missing data

Trial design

172 participants in 2 patient groups

Benign Thyroid Pathologies
Description:
Nodular Goiter Graves Diseases Tocsic Thyroid Nodular Disease
Treatment:
Procedure: Thyroidectomy, Bilaterally Total
Procedure: Thyroidectomy, Unilaterally Total
Procedure: Thyroidectomy, Near Total
Procedure: Thyroidectomy, Complementary
Thyroid Cancer Cases
Description:
Papillary Thyroid Carcinoma Medullary Thyroid Carcinoma Hurthle Cell Carcinoma Anaplastic Thyroid Carcinoma
Treatment:
Procedure: Thyroidectomy, Bilaterally Total
Procedure: Thyroidectomy, Unilaterally Total
Procedure: Thyroidectomy, Near Total
Procedure: Thyroidectomy, Complementary

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems